增长差异化因子15 (GDF-15),是心力衰竭管理中的新生物标志物
Khalid Sawalha1,2, Nicholas B Norgard3, Betty M Drees4
1Cardiometabolic Medicine Fellowship, University of Missouri-Kansas City, Kansas City, MO, USA. Ksawalha@aol.com.
Current heart failure reports
|June 8, 2023
概括
生物标志物有助于医学诊断和预后. 增长区分因子 (GDF) -15显示为预测心力衰竭 (HF) 发病率和死亡率的新型生物标志物.
科学领域:
- 生物医学科学 生物医学科学
- 心血管医学 心血管医学
- 生物标志物研究的研究.
背景情况:
- 生物标志物对于疾病查,诊断,表征,监测和预后至关重要.
- 尿酸是目前心力衰竭 (HF) 诊断和预后的黄金标准.
- 对于HF治疗监测 natriuretic的临床实用性仍在研究中.
研究的目的:
- 审查生物标志物在医学中的演变作用,特别是在心力衰竭 (HF).
- 突出用于HF诊断和预后的新兴生物标志物.
- 强调生长差异化因子 (GDF) -15作为HF预后生物标志物的潜力.
主要方法:
- 医学和心脏病学当前生物标志物应用的文献综述.
- 对心力衰竭 (HF) 的现有和新兴生物标志物的分析.
- 专注于高频增长差异化因子 (GDF) -15在HF中的预后潜力.
主要成果:
- 生物标志物在测量方便性,成本和速度方面比传统的临床终点具有优势.
- 虽然尿酸被广泛使用,但其他生物标志物正在对HF进行研究.
- 目前没有新的生物标志物是高频特异性或推用于常规临床使用.
- 增长差异化因子 (GDF) -15表明在高频中提供预后信息的潜力.
结论:
- 生物标志物是现代医学不可或缺的组成部分,提供多功能应用.
- 增长差异化因子 (GDF) -15是预测心力衰竭 (HF) 结果的有希望的新兴生物标志物.
- 需要进一步的研究来验证GDF-15和其他新型生物标志物用于HF的常规临床实践.
更多相关视频
相关概念视频
01:29Heart Failure II: Pathophysiology
16
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
16
01:30Heart Failure IV: Classification and Diagnostic Evaluation
21
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
21
01:17Pathophysiology of Heart Failure
1.7K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.7K
01:30Cardiomyopathy II: Dilated Cardiomyopathy
12
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
12
01:30Heart Failure V: Medical Management
16
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
16
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
127
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
127